Zika Virus- insights from old papers when you can get them
Hunting for information on the Zika virus has revealed several insights for me, both of them point to areas that are obvious. 1. Researchers may have missed out by not reading anything older than a few...
View ArticleClik here to view.
An illustration of the virus and summary of Research Priorities to Inform...
Late last week I was contacted by John Liebler a science and medicine illustrator and he had seen the Zika glycoprotein E homology model and wanted to use it to produce an image of the virus. After...
View ArticleZika Virus – getting some research moving on drug discovery
Following my last post / plea I have been a little preoccupied trying to find scientists that could : 1. contribute to an open Zika virus drug discovery effort 2. Help write a perspective that...
View ArticleClik here to view.
Using more online software to make predictions for BIA 10-2474
To continue the theme of the last few posts on the BIA 10-2474 compound in which I have used over 2000 Bayesian models and an App as well as another groups target prediction tool. To take this a bit...
View Article2015 in review
2015 saw the continuation of some research themes from 2014, namely some work on Ebola, rare diseases and Bayesian models for neglected diseases. At the end of the year several papers are in press for...
View ArticleACS 2015, chemistry talks, posters and Tattoo!
I am just back from a very busy trip to Boston for the ACS. It was great to meet up with many people I see only rarely, at these meetings as well as meet new people including one with a molecule tattoo...
View ArticleTurning points and games with a purpose
Today I was talking to one of my old mentors from my postdoc days (in big pharma), for the first time in a few years. I realized that working with him and exposure to computational chemistry software...
View ArticleClik here to view.
Open Source Bayesian Models (X2)
For the last 5-6 years I have been kind of obsessed (in a good way) with how perhaps we could try to get computational machine learning models for drug discovery to a point where they could be shared....
View ArticleWhere is the big Pharma Knight riding in to slay Ebola?
In full disclosure my better half works for a big pharma, this is not going to hold me back from writing what I am sure everyone is thinking. It saddens me as someone who worked for big pharma (until...
View ArticleA pharmacophore for compounds active against Ebola
I was looking through Pubmed yesterday looking for repurposing efforts applied to Ebola and found the paper by Madrid et al. This described many hits, including chloroquine and amodiaquine. Then I was...
View ArticleDéjà vu – Another family affected by a rare disease trying to find a cure
During my trip to San Francisco this week I had the opportunity and honor to meet with Matt Wilsey, one of the parents of a child (Grace) with a rare disease and the President of the Grace Wilsey...
View ArticleCould the community contribute to an ACS Session for Jean-Claude Bradley?
Antony Williams and I were discussing last week ways to remember Jean-Claude Bradley. One way might be a session at the ACS in 2015, the 10th anniversary of starting his open notebook. Who would be...
View ArticleThe Measure of the Man
It has been a truly awful week. A colleague, Jean-Claude Bradley passed away. I found out on Tuesday while traveling. I was stunned. We had met several times, enjoyed lunches in a pub across from his...
View ArticleNew ACS initiative to encourage open access?
I just received the following email: Have you heard of ACS Author Rewards? ACS Author Rewards will provide the published corresponding author of each peer-reviewed article published in 2014 with two...
View ArticleACS session summary – Neglected and Rare Disease Drug Discovery Needs Open Data
Here is a summary of the session Co-chaired by Sean Ekins, Antony Williams and Joel S. Freundlich at the ACS on Sunday. The session consisted of 3 presentations and 1 no show. The first talk was given...
View ArticlePredicting Targets for TB Phenotypic Screening Hits and Openess of data and...
So far the only readily accessible, free approach to predicting TB targets is TB Mobile developed for iOS and Android with Alex Clark. While relatively crude the app does allow look up and similarity...
View ArticleWhy Are We Still Doing Industrial Age Drug Discovery For Neglected Diseases...
Modern Times, one of my favorite Charlie Chaplin films was the latest inspiration for a little set of slides that summarizes a developing set of ideas for neglected disease research, specifically the...
View ArticleBeing paid to publish in journals- an incentive?
[Right up front I will remind you of any potential conflicts of interest as I am on the editorial board of Pharmaceutical Research (Springer), Drug Discovery Today (Elsevier), Mutation Research Reviews...
View ArticleClik here to view.
Why does this issue still give me nightmares?
A week or so ago I was seriously contemplating giving up blogging after just a so-so level of interest over 2 years and a couple of spikes that really only corresponded to issues around database...
View ArticleAmerican Chemical Society 2013 Meeting – New Orleans
I am just back from the 2013 American Chemical Society in New Orleans at which I co-chaired 2 sessions in CINF. Lots of gumbo and jambalya were consumed. A very busy meeting, so much so that I barely...
View Article
